AbbVie reported $17.4 billion in sales, $200 million above expectations, and raised its yearly sales forecast. Future gains from its pipeline are not assured, but strong results and new approvals support better prospects.
That gives AbbVie more support for its growth plans. New approvals and pipeline programs create more chances to expand sales, but future gains depend on successful development and patient demand.
Follow AbbVie Inc (ABBV) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ABBV